News

The molecular mechanisms behind the action of the hepatitis B and D virus inhibitor bulevirtide have been revealed, potentially paving the way to more targeted treatments.

A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine scientists have found. The discovery has important implications for preventing severe COVID-19.

Inflammation plays a major role in allergic diseases, affecting at least 17 million people in France, including 4 million asthmatics. One of the molecules that initiates this process in the respiratory tract has just been identified.

Recently, ADA Forsyth scientists exploring the complex interactions of microbes in the oral microbiome discovered a third player influencing the phage-bacterial arms race – ultrasmall bacterial parasites, called Saccharibacteria or TM7.

A gene mutation associated with a rare neurological disorder and increased susceptibility to viral infections may be treatable with oleic acid.

Engineered bacteria can produce a plastic modifier that makes renewably sourced plastic more processable, more fracture resistant and highly biodegradable even in sea water.

Researchers at the Netherlands Cancer Institute have compiled a detailed catalog of bacteria living in cancer metastases. They shed light on the diversity of these co-inhabitants and how they might interact with cancer cells and their surroundings.

People with long COVID have distinct patterns of inflammation detectable in the blood, which could potentially be targeted with immune therapies, reveals new research.

Language models can be used to home in on partial genome sequences and optimize those sequences to study biology and improve medicine, and have designed more effective mRNA vaccines.

An oral vaccine against recurrent UTIs could reduce the need for antibiotic treatment.